| Primary |
| Hypertension |
42.9% |
| Drug Use For Unknown Indication |
31.9% |
| Benign Prostatic Hyperplasia |
6.6% |
| Ill-defined Disorder |
6.6% |
| Renal Transplant |
2.2% |
| Staphylococcal Infection |
2.2% |
| Blood Cholesterol Increased |
1.1% |
| Blood Pressure |
1.1% |
| Cardiomyopathy |
1.1% |
| Depression |
1.1% |
| Hepatitis B |
1.1% |
| Hyperlipidaemia |
1.1% |
| Prostatitis |
1.1% |
|
| Lethargy |
12.9% |
| Angioneurotic Oedema |
9.7% |
| Death |
6.5% |
| Drug Exposure During Pregnancy |
6.5% |
| Hypertension |
6.5% |
| Inguinal Hernia Repair |
6.5% |
| Orthostatic Hypotension |
6.5% |
| Prostate Cancer |
6.5% |
| Atrial Fibrillation |
3.2% |
| Cardiac Discomfort |
3.2% |
| Cataract |
3.2% |
| Completed Suicide |
3.2% |
| Condition Aggravated |
3.2% |
| Dyspnoea |
3.2% |
| Erectile Dysfunction |
3.2% |
| Fall |
3.2% |
| Floppy Iris Syndrome |
3.2% |
| Headache |
3.2% |
| Leukocytoclastic Vasculitis |
3.2% |
| Medication Residue |
3.2% |
|
| Secondary |
| Hypertension |
32.2% |
| Drug Use For Unknown Indication |
28.1% |
| Ill-defined Disorder |
10.3% |
| Product Used For Unknown Indication |
4.8% |
| Staphylococcal Infection |
4.1% |
| Anaesthesia |
3.4% |
| Blood Pressure Abnormal |
3.4% |
| Blood Pressure Increased |
2.7% |
| Bladder Disorder |
2.1% |
| Immunosuppressant Drug Therapy |
1.4% |
| Prostate Examination Abnormal |
1.4% |
| Aortic Dissection |
0.7% |
| Bacterial Infection |
0.7% |
| Blood Cholesterol Increased |
0.7% |
| Erectile Dysfunction |
0.7% |
| Fibromyalgia |
0.7% |
| Hyperlipidaemia |
0.7% |
| Renal Transplant |
0.7% |
| Rheumatoid Arthritis |
0.7% |
| Tuberculous Pleurisy |
0.7% |
|
| Drug Interaction |
12.9% |
| Hypertension |
9.7% |
| Anaphylactic Reaction |
6.5% |
| Completed Suicide |
6.5% |
| Death |
6.5% |
| Orthostatic Hypotension |
6.5% |
| Thrombocytopenia |
6.5% |
| Vomiting |
6.5% |
| Abnormal Behaviour |
3.2% |
| Atrial Flutter |
3.2% |
| Cardiac Failure |
3.2% |
| Disability |
3.2% |
| Heart Rate Increased |
3.2% |
| Kidney Transplant Rejection |
3.2% |
| Liver Function Test Abnormal |
3.2% |
| Multiple Drug Overdose |
3.2% |
| Myalgia |
3.2% |
| Nasal Congestion |
3.2% |
| Nausea |
3.2% |
| No Therapeutic Response |
3.2% |
|
| Concomitant |
| Prophylaxis Against Transplant Rejection |
20.1% |
| Hypertension |
15.3% |
| Product Used For Unknown Indication |
11.1% |
| Type 2 Diabetes Mellitus |
7.9% |
| Diabetes Mellitus |
5.8% |
| Myocardial Infarction |
5.3% |
| Plasma Cell Myeloma |
4.2% |
| Renal Transplant |
3.7% |
| Drug Use For Unknown Indication |
3.2% |
| Depression |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Renal Cell Carcinoma Stage Unspecified |
2.6% |
| Asthma |
2.1% |
| Biliary Neoplasm |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Colorectal Cancer Metastatic |
2.1% |
| Myelodysplastic Syndrome |
2.1% |
| Back Pain |
1.6% |
| Chronic Myeloid Leukaemia |
1.6% |
| Erectile Dysfunction |
1.6% |
|
| White Blood Cell Count Decreased |
10.1% |
| Vascular Graft Complication |
7.6% |
| Vomiting |
7.6% |
| Drug Ineffective |
6.3% |
| Myocardial Infarction |
6.3% |
| Hypomagnesaemia |
5.1% |
| Joint Swelling |
5.1% |
| Myalgia |
5.1% |
| Tremor |
5.1% |
| Weight Increased |
5.1% |
| Blood Glucose Increased |
3.8% |
| Hyperkalaemia |
3.8% |
| Pain |
3.8% |
| Product Quality Issue |
3.8% |
| Pyrexia |
3.8% |
| Rhabdomyolysis |
3.8% |
| Tubulointerstitial Nephritis |
3.8% |
| Ventricular Fibrillation |
3.8% |
| Weight Decreased |
3.8% |
| Drug Interaction |
2.5% |
|
